Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Negative Survival Impact of High Radiation Doses to Neural Stem Cells Niches in an IDH-Wild-Type Glioblastoma Population.

Muracciole X, El-Amine W, Tabouret E, Boucekine M, Barlier A, Petrirena G, Harivony T, Solignac L, Chinot OL, Macagno N, Figarella-Branger D, Padovani L.

Front Oncol. 2018 Oct 4;8:426. doi: 10.3389/fonc.2018.00426. eCollection 2018.

2.

Evaluation of high ipsilateral subventricular zone radiation therapy dose in glioblastoma: a pooled analysis.

Lee P, Eppinga W, Lagerwaard F, Cloughesy T, Slotman B, Nghiemphu PL, Wang PC, Kupelian P, Agazaryan N, Demarco J, Selch MT, Steinberg M, Kang JJ.

Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):609-15. doi: 10.1016/j.ijrobp.2013.01.009. Epub 2013 Feb 22.

PMID:
23462418
3.

Increased subventricular zone radiation dose correlates with survival in glioblastoma patients after gross total resection.

Chen L, Guerrero-Cazares H, Ye X, Ford E, McNutt T, Kleinberg L, Lim M, Chaichana K, Quinones-Hinojosa A, Redmond K.

Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):616-22. doi: 10.1016/j.ijrobp.2013.02.014. Epub 2013 Mar 26.

4.

Can irradiation of potential cancer stem-cell niche in the subventricular zone influence survival in patients with newly diagnosed glioblastoma?

Gupta T, Nair V, Paul SN, Kannan S, Moiyadi A, Epari S, Jalali R.

J Neurooncol. 2012 Aug;109(1):195-203. doi: 10.1007/s11060-012-0887-3. Epub 2012 May 4.

PMID:
22555992
5.

Impact of subventricular zone irradiation on outcome of patients with glioblastoma.

Mathew BS, Kaliyath SB, Krishnan J, Bhasi S.

J Cancer Res Ther. 2018 Oct-Dec;14(6):1202-1206. doi: 10.4103/jcrt.JCRT_295_17.

6.

Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant glioma.

Evers P, Lee PP, DeMarco J, Agazaryan N, Sayre JW, Selch M, Pajonk F.

BMC Cancer. 2010 Jul 21;10:384. doi: 10.1186/1471-2407-10-384.

7.

Do Increased Doses to Stem-Cell Niches during Radiation Therapy Improve Glioblastoma Survival?

Adeberg S, Harrabi SB, Bougatf N, Bernhardt D, Mohr A, Rieber J, Koelsche C, Rieken S, Debus J.

Stem Cells Int. 2016;2016:8793462. doi: 10.1155/2016/8793462. Epub 2016 Jun 27.

8.

Subventricular zones: new key targets for glioblastoma treatment.

Khalifa J, Tensaouti F, Lusque A, Plas B, Lotterie JA, Benouaich-Amiel A, Uro-Coste E, Lubrano V, Cohen-Jonathan Moyal E.

Radiat Oncol. 2017 Apr 20;12(1):67. doi: 10.1186/s13014-017-0791-2.

9.

Dose-escalated intensity-modulated radiotherapy and irradiation of subventricular zones in relation to tumor control outcomes of patients with glioblastoma multiforme.

Kusumawidjaja G, Gan PZ, Ong WS, Teyateeti A, Dankulchai P, Tan DY, Chua ET, Chua KL, Tham CK, Wong FY, Chua ML.

Onco Targets Ther. 2016 Mar 2;9:1115-22. doi: 10.2147/OTT.S96509. eCollection 2016.

10.

Relationship between survival and increased radiation dose to subventricular zone in glioblastoma is controversial.

Elicin O, Inac E, Uzel EK, Karacam S, Uzel OE.

J Neurooncol. 2014 Jun;118(2):413-419. doi: 10.1007/s11060-014-1424-3. Epub 2014 Mar 26. Erratum in: J Neurooncol. 2014 Jun;118(2):421.

PMID:
24668610
11.

Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.

Iaccarino C, Orlandi E, Ruggeri F, Nicoli D, Torricelli F, Maggi M, Cerasti D, Pisanello A, Pedrazzi G, Froio E, Crafa P, D'Abbiero N, Michiara M, Ghadirpour R, Servadei F.

Clin Neurol Neurosurg. 2015 May;132:1-8. doi: 10.1016/j.clineuro.2015.01.029. Epub 2015 Feb 7.

PMID:
25723791
12.
13.

Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525.

Bell EH, Pugh SL, McElroy JP, Gilbert MR, Mehta M, Klimowicz AC, Magliocco A, Bredel M, Robe P, Grosu AL, Stupp R, Curran W Jr, Becker AP, Salavaggione AL, Barnholtz-Sloan JS, Aldape K, Blumenthal DT, Brown PD, Glass J, Souhami L, Lee RJ, Brachman D, Flickinger J, Won M, Chakravarti A.

JAMA Oncol. 2017 Jun 1;3(6):784-792. doi: 10.1001/jamaoncol.2016.6020.

14.

Influence of incidental radiation dose in the subventricular zone on survival in patients with glioblastoma multiforme treated with surgery, radiotherapy, and temozolomide.

Foro Arnalot P, Pera O, Rodriguez N, Sanz X, Reig A, Membrive I, Ortiz A, Granados R, Algara M.

Clin Transl Oncol. 2017 Oct;19(10):1225-1231. doi: 10.1007/s12094-017-1659-5. Epub 2017 Apr 7.

PMID:
28389881
15.
16.

MGMT gene promoter methylation as a potent prognostic factor in glioblastoma treated with temozolomide-based chemoradiotherapy: a single-institution study.

Kim YS, Kim SH, Cho J, Kim JW, Chang JH, Kim DS, Lee KS, Suh CO.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):661-7. doi: 10.1016/j.ijrobp.2011.12.086. Epub 2012 Mar 11.

PMID:
22414280
17.

Sparing of the neural stem cell compartment during whole-brain radiation therapy: a dosimetric study using helical tomotherapy.

Marsh JC, Godbole RH, Herskovic AM, Gielda BT, Turian JV.

Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):946-54. doi: 10.1016/j.ijrobp.2009.12.012. Epub 2010 May 14.

PMID:
20472348
18.

Location of subventricular zone recurrence and its radiation dose predicts survival in patients with glioblastoma.

Weinberg BD, Boreta L, Braunstein S, Cha S.

J Neurooncol. 2018 Jul;138(3):549-556. doi: 10.1007/s11060-018-2822-8. Epub 2018 Mar 15.

PMID:
29546530
19.

Radiotherapy plus temozolomide in elderly patients with glioblastoma: a "real-life" report.

Biau J, Chautard E, De Schlichting E, Dupic G, Pereira B, Fogli A, Müller-Barthélémy M, Dalloz P, Khalil T, Dillies AF, Durando X, Godfraind C, Verrelle P.

Radiat Oncol. 2017 Dec 6;12(1):197. doi: 10.1186/s13014-017-0929-2.

20.

MGMT promoter methylation status as a prognostic factor for the outcome of gamma knife radiosurgery for recurrent glioblastoma.

Kim BS, Kong DS, Seol HJ, Nam DH, Lee JI.

J Neurooncol. 2017 Jul;133(3):615-622. doi: 10.1007/s11060-017-2478-9. Epub 2017 May 23.

PMID:
28536992

Supplemental Content

Support Center